Role of Gut Microbiota in the Development and Management of Rheumatoid Arthritis: A Narrative Review
- PMID: 38152780
- PMCID: PMC10751463
- DOI: 10.7759/cureus.49458
Role of Gut Microbiota in the Development and Management of Rheumatoid Arthritis: A Narrative Review
Abstract
Rheumatoid arthritis is an autoimmune condition that damages and inflames the joints. It causes severe disability and lowers the quality of life. While the precise cause of rheumatoid arthritis is still unknown, mounting evidence suggests that the gut microbiota, a diverse colony of bacteria that inhabits the gastrointestinal tract, may play a vital role in the progression and management of this debilitating condition. By evaluating relationships, probable processes, and therapeutic ramifications, this narrative review intends to examine the complex relationship between intestinal microbiota and rheumatoid arthritis. Additionally, for the management of rheumatoid arthritis, the review will assess prospective therapeutic approaches that target the gut flora. Multiple studies have shown that people with rheumatoid arthritis have dysbiosis or an imbalance in their gut microbial ecosystems. Increased intestinal permeability has been linked to changes in the gut microbiota, which allows the transfer of bacterial products into the bloodstream. A search was undertaken through PubMed in June 2023 using keywords like "microbiota", "rheumatoid arthritis" and "treatment". Overall 42 articles were included. Probiotics, prebiotics, and dietary changes are some examples of therapies that can be used to modify the gut microbiota and lessen symptoms, slower the progression of the disease, and enhance therapy results. Understanding the interplay between intestinal microbiota and rheumatoid arthritis will pave the way for innovative and personalized therapeutic interventions that could revolutionize the management of this chronic autoimmune disease.
Keywords: development; intestinal dysbiosis; microbiota; rheumatoid arthritis; treatment.
Copyright © 2023, Godha et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities.Front Immunol. 2022 Sep 8;13:1007165. doi: 10.3389/fimmu.2022.1007165. eCollection 2022. Front Immunol. 2022. PMID: 36159786 Free PMC article. Review.
-
Triggers and regulation: the gut microbiome in rheumatoid arthritis.Expert Rev Clin Immunol. 2023 Jul-Dec;19(12):1449-1456. doi: 10.1080/1744666X.2023.2260103. Epub 2023 Sep 15. Expert Rev Clin Immunol. 2023. PMID: 37712213
-
Modification of Gut Microbiota in Inflammatory Arthritis: Highlights and Future Challenges.Curr Rheumatol Rep. 2021 Jul 3;23(8):67. doi: 10.1007/s11926-021-01031-9. Curr Rheumatol Rep. 2021. PMID: 34218340 Review.
-
Altered gut microbiota in RA: implications for treatment.Z Rheumatol. 2017 Jun;76(5):451-457. doi: 10.1007/s00393-016-0237-5. Z Rheumatol. 2017. PMID: 27909795 Review. English.
-
Rheumatoid arthritis and the intestinal microbiome: probiotics as a potential therapy.Front Immunol. 2024 Mar 6;15:1331486. doi: 10.3389/fimmu.2024.1331486. eCollection 2024. Front Immunol. 2024. PMID: 38510244 Free PMC article. Review.
Cited by
-
Nature of the Association between Rheumatoid Arthritis and Cervical Cancer and Its Potential Therapeutic Implications.Nutrients. 2024 Aug 5;16(15):2569. doi: 10.3390/nu16152569. Nutrients. 2024. PMID: 39125448 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources